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Compare to autologous NK cells, allogeneic NK cells
have more anti-tumor cytotoxicity without GVHD.
Adoptive transfer of allo-reactive NK cell can be ideally
used combined with other immunotherapy. However, in
vivo persistency of transferred NK cells in the recipients
are still an obstacle in NK cell-based immunotherapy. As
most of NK cells purified from peripheral blood of
donors are fully differentiated, their short lifespan might
be a reason. In this study, we developed a new method of
“young” human NK cell generation which can be used
for immune cell therapy.
CD34+ hematopoietic precursor/stem cells were purified
from umbilical cord blood and differentiated into NK cells
in vitro. Stem cell expansion and lineage commitment can
be modulated by stromal cells and exogenous cytokines.
Most of CD34+ cells express receptors for IL-3, Flt3-L,
and SCF, while a small subset expressed IL-7Ra. Without
feeder cells, CD34+ cells were initially expanded with exo-
genous cytokines (IL-3, Flt3-L, IL-15, SCF, and IL-7) but
most of cells were differentiated into myeloid cells. When
the precursor cells were co-cultured with feeder cells
(murine embryonic liver stromal cell line EL08-1D2),
CD56+ NK cells were successfully generated after 3 weeks
(x20,000 fold expansion). Interestingly, as use of feeder
cells was necessary for NK cell differentiation during early
days (D0 to 5), feeder cell interaction may have a role on
the proliferation of early lymphoid precursors or myeloid/
lymphoid fate decision of hematopoietic stem cells. When
we used EL08-1D2 feeder cells transduced with human
Notch ligand DLL4, most of hematopoietic precursors
were differentiated into lymphoid lineage cells.
Some of generated CD56+ cells were non-cytotoxic
group3 innate lymphoid cells (ILC3s), and ILC3s do not
express most of NK cytotoxic receptors (NKG2D, NKp30,
NKp46, 2B4, CD94, NKG2A, DNAM-1, and CD16). Cyto-
toxic NK cells can be discriminated from ILC3s based on
CD11a/CD18 (LFA-1) expression, and this was confirmed
using CD107a assay and IFN-g staining. While ILC3s
require SCF and IL-7 for their generation, NK cells can be
successfully generated with IL-15 and Flt-3L only. As
small populations of the generated NK cells express KIRs
which are essential for allogeneic cytotoxicity, we epigen-
etically induced KIR expression using a demethylating
agent 5-aza-2′-deoxycytidine during NK cell differentia-
tion. When 5-aza-2′-deoxycytidine was treated on imma-
ture NK cells (D14 to 21), it efficiently induced KIR
expression while it did not on fully differentiated NK cells
(at D21). In conclusion, this new method can be used for
novel NK cell based immunotherapy.
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